Vir Biotechnology (NASDAQ:VIR) Earnings Information
Vir Biotechnology last announced its earnings results on November 10th, 2020. The reported ($0.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.57) by $0.10. The business had revenue of $1.93 million for the quarter, compared to analyst estimates of $2.65 million. Vir Biotechnology has generated ($5.76) earnings per share over the last year. Vir Biotechnology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 25th, 2021 based off prior year's report dates.
Vir Biotechnology Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Vir Biotechnology (NASDAQ:VIR) Earnings Estimates
Current Year EPS Consensus Estimate: $-2.36 EPS
Next Year EPS Consensus Estimate: $-2.9 EPS
Vir Biotechnology (NASDAQ VIR) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)